Alerts will be sent to your verified email
Verify Email
GEL
|
Gautam Exim
|
Cerebra Integ. Tech
|
Astal Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.72 % | -1.34 % | 5.65 % |
|
5yr average Equity Multiplier
|
2.76 | 1.52 | 1.45 |
|
5yr Average Asset Turnover Ratio
|
6.36 | 0.3 | 0.4 |
|
5yr Avg Net Profit Margin
|
0.23 % | -13.9 % | 3.54 % |
|
Price to Book
|
6.91 | 0.57 | 2.47 |
|
P/E
|
688.71 | 0.0 | 9.59 |
|
5yr Avg Cash Conversion Cycle
|
83.7 Days | 765.04 Days | 83.93 Days |
|
Inventory Days
|
0.0 | 113.07 Days | 12.25 Days |
|
Days Receivable
|
91.2 Days | 916.46 Days | 123.54 Days |
|
Days Payable
|
13.0 Days | 375.27 Days | 125.63 Days |
|
5yr Average Interest Coverage Ratio
|
1.4 | 1.54 | 21.93 |
|
5yr Avg ROCE
|
11.56 % | 3.66 % | 7.95 % |
|
5yr Avg Operating Profit Margin
|
0.15 % | -2.53 % | 4.11 % |
|
5 yr average Debt to Equity
|
1.06 | 0.11 | 0.08 |
|
5yr CAGR Net Profit
|
-27.74 % | n/a | 289.2 % |
|
5yr Average Return on Assets
|
1.27 % | -0.8 % | 3.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.92 % | 0.84 % | 18.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -4.21 % | -48.62 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Gautam Exim
|
Cerebra Integ. Tech
|
Astal Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|